Doubting UC Researchers May Sink CRISPR Appeal
It doesn’t look as if Harvard and MIT will have to share its patents on revolutionary CRISPR-Cas9 gene editing technology with the University of California any time soon. The U.S. Court of Appeals sounded skeptical of the appeal brought Monday by UC and Munger, Tolles & Olson partner Donald Verrilli …